Compare McKesson Corporation (MCK) vs Monster Beverage Corp (MNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Monster Beverage Corp — how do they compare? McKesson Corporation trades at $930 (market cap $108.46B), while Monster Beverage Corp trades at $43.62 (market cap $85.51B). The key difference: McKesson Corporation is the larger of the two by market cap, and McKesson Corporation pays a 0.4% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Monster Beverage Corp for 72 Days on average.
| MCK | MNST | |
|---|---|---|
Market Cap | $108.46B | $85.51B |
Volume | 712,607 | 8,569,709 |
Sector | Health | Consumer Staples |
52-Week High | $995.69 | $49.97 |
52-Week Low | $725.17 | $33.16 |
Typical Hold Time | 74 Days | 72 Days |
Enterprise Value | $115.00B | $83.81B |
Dividend Yield | 0.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $910.33, down 1.23% today, but maintains strong analyst support with 80.65% buy ratings and a $956.43 consensus price target. The stock shows bullish technical momentum with recent earnings beats and a major distribution agreement extension with CVS Health through 2032. Revenue growth has accelerated from $264B in 2022 to $359B in 2025, though net margins remain thin at 1.12%.
MCK presents a compelling growth story with consistent earnings outperformance and strategic partnerships driving long-term visibility. However, investors face risks from margin compression, drug pricing pressures, and high leverage with negative shareholder equity. The current valuation at 24.42x P/E appears reasonable given the company's market leadership and oncology growth prospects.
Monster Beverage (MNST) trades at $42.88, down 0.86% on the day, with technical indicators showing bearish momentum despite strong fundamental performance. The company reported robust Q2 2026 earnings, beating estimates with $0.30 EPS, and maintains impressive profitability metrics including 55.55% gross margin and 23.08% net income margin. Recent news highlights Monster's debt-free balance sheet and international expansion driving 35% overseas sales growth.
While valuation multiples appear elevated (P/E 39.7, P/S 9.18), Monster's consistent earnings beats and analyst consensus price target of $98.22 suggest significant upside potential. Key risks include regulatory challenges in international markets and competitive pressures, but the company's strong cash flow generation and market position support long-term growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →
